Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine R Tuttle

Showing results (41-50 of 355) with videos related to

Pageof 36
Sort By:
Kidney360|November 20, 2025
Real-World Data: Critical Evidence to Better Understanding Kidney Benefits with Sodium-Glucose Cotransporter 2 InhibitorsJoshua J Neumiller, Katherine R Tuttle
Advances in Chronic Kidney Disease|April 12, 2005
The next generation of diabetic nephropathy therapies: an updateMark E Williams, Katherine R Tuttle
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 5, 2003
A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibitionKatherine R Tuttle, Pamela W Anderson
Current Opinion in Nephrology and Hypertension|August 13, 2008
Elevations in serum creatinine with RAAS blockade: why isn't it a sign of kidney injury?Michael J Ryan, Katherine R Tuttle
Archives of Internal Medicine|June 10, 2009
The "Eco-Atkins" diet: new twist on an old taleKatherine R Tuttle, Joan E Milton
Clinical Journal of the American Society of Nephrology : CJASN|April 14, 2021
GLP-1 Receptor Agonists in Diabetic Kidney DiseaseErin D Michos, Katherine R Tuttle
Diabetes, Obesity & Metabolism|February 4, 2020
Evidence-based treatment of hyperglycaemia with incretin therapies in patients with type 2 diabetes and advanced chronic kidney diseaseKatherine R Tuttle, Janet B McGill
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 17, 2009
Prevention of diabetic kidney disease: negative clinical trials with renin-angiotensin system inhibitorsRobert G Nelson, Katherine R Tuttle
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2019
Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney DiseaseKatherine R Tuttle, David Z Cherney,
Annals of Internal Medicine|February 5, 2020
Web Exclusive. Annals On Call - The Good, the Bad, and the Ugly-the Sequel: GLP1 AgonistsRobert M Centor, Katherine R Tuttle
Pageof 36

Showing results (41-50 of 355) with videos related to

Sort By:
Pageof 36
Kidney360|November 20, 2025
Real-World Data: Critical Evidence to Better Understanding Kidney Benefits with Sodium-Glucose Cotransporter 2 InhibitorsJoshua J Neumiller, Katherine R Tuttle
Advances in Chronic Kidney Disease|April 12, 2005
The next generation of diabetic nephropathy therapies: an updateMark E Williams, Katherine R Tuttle
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 5, 2003
A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibitionKatherine R Tuttle, Pamela W Anderson
Current Opinion in Nephrology and Hypertension|August 13, 2008
Elevations in serum creatinine with RAAS blockade: why isn't it a sign of kidney injury?Michael J Ryan, Katherine R Tuttle
Archives of Internal Medicine|June 10, 2009
The "Eco-Atkins" diet: new twist on an old taleKatherine R Tuttle, Joan E Milton
Clinical Journal of the American Society of Nephrology : CJASN|April 14, 2021
GLP-1 Receptor Agonists in Diabetic Kidney DiseaseErin D Michos, Katherine R Tuttle
Diabetes, Obesity & Metabolism|February 4, 2020
Evidence-based treatment of hyperglycaemia with incretin therapies in patients with type 2 diabetes and advanced chronic kidney diseaseKatherine R Tuttle, Janet B McGill
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 17, 2009
Prevention of diabetic kidney disease: negative clinical trials with renin-angiotensin system inhibitorsRobert G Nelson, Katherine R Tuttle
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2019
Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney DiseaseKatherine R Tuttle, David Z Cherney,
Annals of Internal Medicine|February 5, 2020
Web Exclusive. Annals On Call - The Good, the Bad, and the Ugly-the Sequel: GLP1 AgonistsRobert M Centor, Katherine R Tuttle
Pageof 36